Synbiotic

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	3

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04804046 (ClinicalTrials.gov)	July 15, 2021	11/3/2021	Synbiotics and Post-op Crohn's Disease	Defining Microbial and Immune Changes Following SynbioticSupplementation in Post-operative Crohn's D ...	Crohn's Disease	Dietary Supplement: Synbiotic;Other: Digestible Maltodextrin	University of Alberta	W. Garfield Weston Foundation	Recruiting	18 Years	75 Years	All	36	N/A	Canada
2	NCT00305409 (ClinicalTrials.gov)	June 2006	20/3/2006	Synbiotic Treatment in Crohn's Disease Patients	Synbiotic Treatment in Crohn's Disease Patients	Crohn's Disease	Drug: Synbiotic (Synergy I / B.longum)	University of Dundee	NULL	Completed	18 Years	79 Years	Both	50	N/A	United Kingdom
3	NCT00587041 (ClinicalTrials.gov)	February 2006	21/12/2007	Use of Oral Probiotics to Reduce Urinary Oxalate Excretion	Use of Oral Probiotics to Reduce Urinary Oxalate Excretion	Nephrolithiasis;Hyperoxaluria;Crohn's Disease	Dietary Supplement: Oxadrop;Dietary Supplement: Agri-King Synbiotic (AKSB);Other: Placebo	Mayo Clinic	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);National Institutes of Heal ...	Completed	18 Years	N/A	All	40	Phase 1/Phase 2	United States

First Previous1Next Last